Frederick W. Goldberg

1.7k total citations
35 papers, 807 citations indexed

About

Frederick W. Goldberg is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Frederick W. Goldberg has authored 35 papers receiving a total of 807 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Organic Chemistry and 6 papers in Oncology. Recurrent topics in Frederick W. Goldberg's work include Asymmetric Hydrogenation and Catalysis (5 papers), Hormonal Regulation and Hypertension (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Frederick W. Goldberg is often cited by papers focused on Asymmetric Hydrogenation and Catalysis (5 papers), Hormonal Regulation and Hypertension (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Frederick W. Goldberg collaborates with scholars based in United Kingdom, United States and Poland. Frederick W. Goldberg's co-authors include Jason G. Kettle, Matthew W. D. Perry, Thierry Kogej, James S. Scott, Andrew V. Turnbull, Philip Magnus, Jian Xiong, V. Lynch, Gillian M. Lamont and Claire J. Russell and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Journal of Clinical Oncology.

In The Last Decade

Frederick W. Goldberg

34 papers receiving 796 citations

Peers

Frederick W. Goldberg
Andrew Fensome United States
Manus Ipek United States
Weixin Xu United States
Wayne Vaccaro United States
Mark Salvati United States
Stuart B. Rosenblum United States
Sajiv K. Nair United States
Klaus Pors United Kingdom
Robert A. Mantei United States
Frederick W. Goldberg
Citations per year, relative to Frederick W. Goldberg Frederick W. Goldberg (= 1×) peers Stefan Jaroch

Countries citing papers authored by Frederick W. Goldberg

Since Specialization
Citations

This map shows the geographic impact of Frederick W. Goldberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederick W. Goldberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederick W. Goldberg more than expected).

Fields of papers citing papers by Frederick W. Goldberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frederick W. Goldberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederick W. Goldberg. The network helps show where Frederick W. Goldberg may publish in the future.

Co-authorship network of co-authors of Frederick W. Goldberg

This figure shows the co-authorship network connecting the top 25 collaborators of Frederick W. Goldberg. A scholar is included among the top collaborators of Frederick W. Goldberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frederick W. Goldberg. Frederick W. Goldberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Atobe, Masakazu, et al.. (2023). α‐Functionalisation of Cyclic Sulfides Enabled by Lithiation Trapping. Angewandte Chemie. 136(2).
2.
Atobe, Masakazu, et al.. (2023). α‐Functionalisation of Cyclic Sulfides Enabled by Lithiation Trapping. Angewandte Chemie International Edition. 63(2). e202314423–e202314423. 5 indexed citations
3.
Clark, Roger, Ronald Tomlinson, Andrea M. Zuhl, et al.. (2023). Chemical Biology Approaches Confirm MCT4 as the Therapeutic Target of a Cellular Optimized Hit. ACS Chemical Biology. 18(2). 296–303. 8 indexed citations
4.
Goldberg, Frederick W., Attilla Ting, David T. Beattie, et al.. (2022). Optimization of hERG and Pharmacokinetic Properties for Basic Dihydro-8H-purin-8-one Inhibitors of DNA-PK. ACS Medicinal Chemistry Letters. 13(8). 1295–1301. 7 indexed citations
5.
Petruzzelli, Michele, Sophie Postel‐Vinay, Elena Garralda, et al.. (2022). Rationale and design of phase 1 FTIH study of FOXP3 antisense oligonucleotide AZD8701 in patients with selected advanced solid tumors.. Journal of Clinical Oncology. 40(16_suppl). TPS3166–TPS3166. 1 indexed citations
6.
Goldberg, Frederick W., M. Raymond V. Finlay, Attilla Ting, et al.. (2019). The Discovery of 7-Methyl-2-[(7-methyl[1,2,4]triazolo[1,5-a]pyridin-6-yl)amino]-9-(tetrahydro-2H-pyran-4-yl)-7,9-dihydro-8H-purin-8-one (AZD7648), a Potent and Selective DNA-Dependent Protein Kinase (DNA-PK) Inhibitor. Journal of Medicinal Chemistry. 63(7). 3461–3471. 66 indexed citations
7.
Critchlow, Susan E., Gareth Hughes, Anna D. Staniszewska, et al.. (2019). Abstract 1207: Reversing lactate-driven immunosuppression using the novel, potent and selective MCT4 inhibitor AZD0095. Cancer Research. 79(13_Supplement). 1207–1207. 5 indexed citations
8.
Spender, Lindsay C., Gail Ferguson, Gareth Hughes, et al.. (2018). Preclinical Evaluation of AZ12601011 and AZ12799734, Inhibitors of Transforming Growth Factor β Superfamily Type 1 Receptors. Molecular Pharmacology. 95(2). 222–234. 26 indexed citations
9.
Lightfoot, Helen L., Frederick W. Goldberg, & Joerg Sedelmeier. (2018). Evolution of Small Molecule Kinase Drugs. ACS Medicinal Chemistry Letters. 10(2). 153–160. 27 indexed citations
10.
McCoull, William, Edward J. Hennessy, Kevin Blades, et al.. (2016). Optimization of Highly Kinase Selective Bis-anilino Pyrimidine PAK1 Inhibitors. ACS Medicinal Chemistry Letters. 7(12). 1118–1123. 20 indexed citations
11.
Robb, Graeme R., Scott Boyd, Alexander G. Dossetter, et al.. (2015). Design of pyrazolo-pyrimidines as 11β-HSD1 inhibitors through optimisation of molecular electrostatic potential. MedChemComm. 6(5). 926–934. 4 indexed citations
12.
Goldberg, Frederick W., et al.. (2014). Designing novel building blocks is an overlooked strategy to improve compound quality. Drug Discovery Today. 20(1). 11–17. 158 indexed citations
13.
McCoull, William, Edward J. Hennessy, Kevin Blades, et al.. (2014). Identification and optimisation of 7-azaindole PAK1 inhibitors with improved potency and kinase selectivity. MedChemComm. 5(10). 1533–1539. 14 indexed citations
14.
Craig, Donald C., et al.. (2013). Aziridine-based concise synthesis of (±)-alstonerine. Chemical Communications. 49(81). 9275–9275. 11 indexed citations
15.
Goldberg, Frederick W., et al.. (2012). Asymmetric synthesis of 2-alkyl-substituted tetrahydroquinolines by an enantioselective aza-Michael reaction. Organic & Biomolecular Chemistry. 10(22). 4424–4424. 34 indexed citations
16.
Goldberg, Frederick W., Alan M. Birch, Andrew G. Leach, et al.. (2012). Discovery and optimization of efficacious neutral 4-amino-6-biphenyl-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-5-one diacylglycerol acyl transferase-1 (DGAT1) inhibitors. MedChemComm. 4(1). 165–174. 2 indexed citations
17.
Pors, Klaus, Frederick W. Goldberg, Christopher P. Leamon, et al.. (2009). The changing landscape of cancer drug discovery: a challenge to the medicinal chemist of tomorrow. Drug Discovery Today. 14(21-22). 1045–1050. 9 indexed citations
18.
Goldberg, Frederick W., Richard A. Ward, Steven J. Powell, et al.. (2009). Rapid Generation of a High Quality Lead for Transforming Growth Factor-β (TGF-β) Type I Receptor (ALK5). Journal of Medicinal Chemistry. 52(23). 7901–7905. 33 indexed citations
19.
Goldberg, Frederick W., et al.. (2005). A Mild Thermal and Acid-Catalyzed Rearrangement of O-Aryl Ethers into ortho-Hydroxy Arenes. Organic Letters. 7(20). 4531–4534. 31 indexed citations
20.
Goldberg, Frederick W.. (1973). INFLUENCE OF THERMAL CUTTING AND ITS QUALITY ON THE FATIGUE STRENGTH OF STEEL. Welding Journal. 52(9). 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026